T. Q. P. Uyeda et al.
FULL PAPER
hydroxybenzotriazole (HOBt, Dojindo, 2.11 g, 15.6 mmol), and di-
cyclohexylcarbodiimide (Sigma–Aldrich, 3.21 g, 15.6 mmol) were
stirred under nitrogen at room temperature overnight (ca. 16 h) and
then at 100 °C for 4 h. Then, ethyl acetate (225 mL) was added,
and the ethyl acetate solution was filtered and washed once each
with 225 mL of saturated aqueous solutions of NaHCO3 and
NaCl. The organic layer was dried with anhydrous Na2SO4, fil-
tered, and concentrated, and the crude product was dried in vacuo
and purified by silica gel flash column chromatography (CH2Cl2/
MeOH, 95:5) to provide 1.23 g (26.6% yield). 1H NMR [300 MHz,
CDCl3(TMS)]: δ = 9.22 (s, 1 H, NHCO), 7.88–6.74 (m, 8 H, aro-
matic protons of azobenzene), 3.91–3.87 (m, 4 H, CH2), 3.09 [s, 6
H, N(CH3)2], 2.81 (m, 2 H, OH), 1.23 (s, 3 H, CH3) ppm. Rf =
0.26 (CH2Cl2/MeOH, 95:5). ESI MS: m/z = 357.2 [M + H]+ (calcd.
357.2).
was obtained after incubation at 55 °C for 12 h and freeze-drying.
All reagents for the synthesis of the oligonucleotide were purchased
from ABI, except for ammonia solution (WAKO).
N-(4-{[4-(Dimethylamino)phenyl]azo}phenyl)acetamide (8): Com-
pound 2 (0.10 g, 0.42 mmol) in CH2Cl2 (1.4 mL) and triethylamine
(0.1 mL) solution was added dropwise under nitrogen to acetyl
chloride (33 mg, 0.42 mmol, WAKO) prepared as a CH2Cl2 solu-
tion (6% v/v, 0.8 mL). The product was added to CH2Cl2 (20 mL),
the solution was filtered, and the organic layer was washed with
saturated aqueous solutions (20 mL) of NaHCO3 (twice) and NaCl
(twice) and then dried with anhydrous Na2SO4. The solution was
concentrated and dried in vacuo. Silica gel column chromatography
(CH2Cl2/MeOH, 95:5) provided 8 (0.10 g, 85% yield). 1H NMR
[300 MHz, [D6]DMSO (TMS)]: δ = 10.17 (s, 1 H, NHCO), 7.77–
6.81 (m, 8 H, aromatic protons of azobenzene), 3.08 [s, 6 H,
N(CH3)2], 2.08 (s, 3 H, CH3) ppm. Rf = 0.44 (CH2Cl2/MeOH,
95:5).
3-[Bis(4-methoxyphenyl)(phenyl)methoxy]-N-{4-[(4-dimethylamino)-
phenylazo]phenyl}-2-(hydroxymethyl)-2-methylpropionamide (4): A
dry pyridine (15 mL) solution of 3 (1.97 g, 5.53 mmol) and 4-(di-
Reversed-Phase HPLC Purification of 6: The sample solution was
filtered (Millex, 0.45 µm, Millipore) before application to the col-
umn (Symmetry C18, 5 µm, 100 Å, Waters) for reversed-phase
HPLC purification (JASCO). The developing solvent flowed for
50 min at a rate of 1 mLmin–1 and was composed of a linear gradi-
ent from 5:95% to 45:55% acetonitrile/water (50 m ammonium
formate) at room temperature. The first major peak was observed
at ca. 17 min, and the second peak was observed ca. 40 s later after
correction for the dead volume. The monitoring wavelength was
260 nm. The results reported in this paper were obtained by use of
the fraction with the longer retention time, although two distinct
spectral profiles corresponding to the (E) and (Z) forms of 4-
DMAzo-tethered 6 were also observed in DMSO with the fraction
of shorter retention time. Furthermore, the time constant for recov-
ery in aqueous solution after flash photolysis was 0.14Ϯ0.1 ms for
the fraction with the shorter retention time, similar to that obtained
for that with the longer retention time.
methylamino)pyridine
(DMAP,
Tokyo
Kasei,
5.66 mg,
0.276 mmol) was cooled under nitrogen with ice, and 4,4Ј-dimeth-
oxytrityl chloride (DMT-Cl, Wako, 2.25 g, 6.63 mmol) in CH2Cl2
(4.5 mL) was added dropwise. After 19 h, CH2Cl2 (60 mL) was
poured into the mixture, and the solution was filtered. After having
been washed with saturated aqueous solutions (60 mL) of NaHCO3
(twice) and NaCl (once), the organic layer was dried with anhy-
drous Na2SO4, the solution was concentrated and dried in vacuo,
and silica gel column chromatography (CH2Cl2/iPrOH/Et3N,
97.5:2.5:1) provided 4 (1.93 g, 53.0% yield). 1H NMR [300 MHz,
CDCl3(TMS)]: δ = 9.45 (s, 1 H, NHCO), 7.87–6.74 (m, 21 H, aro-
matic protons of azobenzene and DMT), 3.79–3.64 (s, 6 H, OCH3,
m, 2 H, CH2OH), 3.44–3.36 (d, 2 H, DMT-OCH2), 3.07 [s, 6 H,
N(CH3)2] 1.35 (s, 3 H, CH3) ppm. Rf = 0.25 (CH2Cl2/iPrOH/Et3N,
97.5:2.5:1). ESI MS: m/z = 659.3 [M + H]+ (calcd. 659.3).
2-{[Bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-3-(4-{[4-(dimeth-
ylamino)phenyl]azo}phenylamino)-2-methyl-3-oxopropyl 2-Cyano-
ethyl diisopropylphosphoramidite (5): In a dry acetonitrile (10 mL)
solution, 2 (0.296 g, 0.45 mmol) and 2-cyanoethyl N,N,NЈ,NЈ-tetra-
ESI and MALDI-TOF Mass Measurements: Compounds 3–5 were
identified by NMR spectroscopy and ESI mass spectrometry (posi-
tive mode, MeOH solvent; ABI). The synthesized oligonucleotide 6
was identified by MALDI-TOF mass spectrometry (negative mode,
THAP matrix; ABI).
isopropylphosphorodiamidite
(Sigma–Aldrich,
0.16 mL,
0.50 mmol) were treated with 1H-tetrazole (Tokyo Kasei, 35 mg,
0.50 mmol). After 1 h, the product was added to ethyl acetate
(100 mL), and the organic solution was filtered and washed with
100 mL portions of saturated aqueous solutions of NaHCO3 and
NaCl, dried with Na2SO4, and desalted by filtration. Finally, the
solvent was removed in vacuo. The resultant product was purified
by silica gel column chromatography (hexane/AcOEt, 2:1) and
dried in vacuo to provide 0.14 g (36.2% yield). 1H NMR
[300 MHz, CDCl3(TMS)]: δ = 9.16 (s, 1 H, NHCO), 7.86–6.74 (m,
21 H, aromatic protons of azobenzene and DMT), 3.85–3.71 (m,
10 H, OCH3, CH2OP, CH2-OP), 3.54–3.46 [m, 2 H, CH(CH3)2],
3.42–3.37 (m, 2 H, DMT-OCH2), 3.08 [s, 6 H, N(CH3)2], 2.56–2.47
(m, 2 H, CH2CN), 1.28–1.07 [m, 15 H, CH(CH3)2, CH3] ppm. Rf
= 0.28 (hexane/AcOEt, 2:1). ESI MS: m/z = 881.5 [M + Na]+
(calcd. 881.4).
UV/Vis Spectroscopy: Spectra of the synthesized oligonucleotide,
4-DMAzo and its derivatives were measured with a DU800 spec-
trophotometer (Beckman). Prior to the (Z)/(E) transition measure-
ments with the spectrophotometer, the sample solutions were irra-
diated with light. The sample cell (quartz) was irradiated with UV
(350 nm) or visible (420 or 550 nm) light from a 150 W Xenon lamp
through a 5 nm slit for 25 min or longer at 20.5Ϯ1 °C by placing
a quartz cuvette containing the sample in the light path of a fluo-
rescence spectrometer (RF-5300PC, Shimadzu). Before each ex-
periment we confirmed that the absorbance of the sample at
425 nm did not change over a 15–30 min period in the dark; this
is an indication that the majority of the 4-DMAzo moieties were
originally in the (E) form, as was also confirmed by NMR analysis
of 8 (data not shown). All procedures were performed in a dark
room.
Synthesis of Photoresponsive Oligonucleotide 6: To prepare the pho-
toresponsive DNA oligonucleotide with an automated synthesizer
(DNA/RNA synthesizer 392/394, ABI), the phosphoramidite
monomer 5 was diluted to 0.1 in dry acetonitrile. Monomer 5
was coupled with a conventional adenine-phosphoramidite mono-
Kinetic Measurement in DMSO: The rate constants of thermal (Z)-
to-(E) isomerization were estimated by first-order analysis of the
absorbance at λ = 425 nm for at least three measurements. The R
values were Ͼ0.99 for all compounds. The mixtures of solute (6 or
the 4-DMAzo derivatives) and DMSO were dried thoroughly by
incubation with molecular sieves for more than 8 h before each
measurement in a dark place. The concentration of each compound
was as follows: 6 (3.9–8.3 µ), 2 (7.1–8.7 µ), 7 (8.3–8.7 µ), and
mer to synthesize the photoresponsive oligonucleotide on
a
0.2 µmol scale. The synthesized oligonucleotide was adsorbed on a
CPG column (500 Å pore size) and eluted by ammonia treatment
for cleavage. The resultant crude product for HPLC purification
1852
www.eurjoc.org
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2007, 1846–1853